Understanding the need for health plans to keep up with the extraordinary advancements in the treatment of cancer that science has achieved over the last 15+ years made the decision for Diversified Group to make OncoSentrics a key component of our cancer management program a relatively simple one. We introduced the OncoSentrics program to our suite of managed care solutions in 2010 with great success for plan members and their employer groups.
Biologics first introduced OncoSentrics in 2005 and has already received accolades from payors for its focus on evidence-based guidelines and integrated clinical care teams specifically for the treatment of cancer.
The OncoSentrics program was developed with the understanding that cancer is not one disease with one clear course of treatment. There are more than 300 distinct types of cancer, varying stages of disease progression and more new cancer medicines than ever emerging from manufacturers’ pipelines. And the world of cancer is constantly changing.
Along with positive developments such as earlier diagnosis, new promising treatments and longer term survival, come higher costs. Although, on average, plans have a 1% incidence rate for cancer diagnosis among enrollees, costs make up about 15% of a plan’s overall healthcare spend. Without a cancer management strategy, cancer treatment costs are projected to escalate at a rate of 233% in just four years.
Biologics’ singular focus on cancer, strong longstanding relationships within the provider community and determination to ease each patient’s health, financial and emotional burden has translated into a robust set of offerings designed to most successfully – and cost-effectively – manage cancer.
Each of the components of OncoSentrics leverage Biologics’ extensive oncology expertise to respond to the growing oncology services market, as well as to the highly individualized needs of cancer patients.
These components include: